Sign in →

Test ID CI Inherited Conjugated Hyperbilirubinemias, 24 Hour, Urine

Useful For

Differential diagnosis of hyperbilirubinemia syndromes between Dubin-Johnson syndrome and Rotor syndrome in patients ≥1 year of age

Method Name

High-Performance Liquid Chromatography (HPLC)

Reporting Name

Inher Conj Hyperbilirubinemias, U

Specimen Type

Urine

Container/Tube: Amber, 60-mL urine bottle (Supply T596)

Specimen Volume: 20-50 mL

Collection Instructions:

1. Patient should abstain from alcohol for at least 24 hours before as well as during the collection period.

2. Collect urine for 24 hours.

3. Add 5 g of sodium carbonate as preservative at start of collection. This preservative is intended to achieve a pH of >7. Do not substitute sodium bicarbonate for sodium carbonate.

4. The container should be refrigerated and protected from light as much as possible during collection.

5. Protect specimen from light.

Additional Information:

1. 24-Hour volume is required.

2. Include a list of medications the patient is currently taking.

3. The pH will generally fall between 7 and 10 if the proper preservative (5 g sodium carbonate) was added to the container before the collection was started.

4. See Urine Preservatives in Special Instructions for multiple collections.

 

Urine Preservative Collection Options

Ambient

No

Refrigerated

No

Frozen

No

6N HCl

No

50% Acetic Acid

No

Na2CO3

Required**

Toluene

No

6N HNO3

No

Boric Acid

No

Thymol

No

**Protect specimen from light.

Specimen Minimum Volume

10 mL

Specimen Stability Information

Specimen Type Temperature Time
Urine Frozen 7 days

Clinical Information

Dubin-Johnson syndrome (DJS) and Rotor syndrome are 2 of the inherited disorders of bilirubin metabolism that result in conjugated hyperbilirubinemia. DJS is inherited as an autosomal recessive trait that is rarely detected before puberty. It is characterized by chronic, nonhemolytic jaundice. Most patients are asymptomatic and the liver typically shows abnormal black pigmentation. The gene responsible for this disorder is a member of the family of ATP-binding cassette transporters located on chromosome 10q24, called MRP2 or cMOAT. This defect impairs liver excretion of conjugated bilirubin and several organic anions from the hepatocytes into the bile. Other liver function tests are normal.

 

Rotor syndrome is a rare condition of the liver and very similar to DJS. It is inherited as an autosomal recessive trait caused by digenic inheritance of homozygous mutations in the SLCO1B1 and SLCO1B3 genes. Biochemically, Rotor syndrome can be distinguished from DJS by a normal functioning gallbladder, normal liver histology, and the different pattern of coproporphyrin isomers excretion.

 

In healthy individuals, the percent of coproporphyrin I excreted relative to the total coproporphyrin excreted in urine is approximately 20% to 45%. In DJS and Rotor syndrome, retention of coproporphyrin III by the liver causes diminished urinary excretion. Consequently the percent of coproporphyrin I to the total coproporphyrin excreted in the urine exceeds the normal range.

 

When the total urinary excretion of coproporphyrin is elevated and the percent of coproporphyrin I to total coproporphyrin exceeds 60%, but is less than 80%, the presentation is most consistent with Rotor syndrome. In patients with DJS, the percentage of coproporphyrin I to total coproporphyrin is typically greater than 80% and the total urinary coproporphyrin excretion is within normal limits. Some overlap may exist so the ratio alone should not be used to distinguish between Rotor or DJS.

Reference Values

COPROPORPHYRIN ISOMERS I AND III

Males

25-150 mcg/24 hours

Females  

 8-110 mcg/24 hours

 

% COPROPORPHYRIN I

20-45%

Cautions

This test is not useful for the evaluation of individuals <1 year of age suspected of having Dubin-Johnson syndrome or Rotor syndrome. Due to normal liver development, coproporphyrin I is primarily excreted in infant urine and cannot be interpreted in the scope of hyperbilirubinemia syndromes.

 

This test is not useful for evaluating patients with suspected porphyrias. For measurement of urine coproporphyrin and uroporphyrin for the workup of porphyria, see PQNU / Porphyrins, Quantitative, 24 Hour, Urine or PQNRU / Porphyrins, Quantitative, Random, Urine.

 

Failure to maintain low temperature and correct pH may allow analyte degradation and result in falsely decreased coproporphyrin III values (ie, false-positives).

Day(s) Performed

Varies

Report Available

3 days (not reported on Saturday or Sunday)

Performing Laboratory

Mayo Medical Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information

84120

NY State Approved

Conditional